4DMedical Limited Stock
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
02:11:01 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.360 AUD | -3.45% |
|
-6.67% | -14.50% |
| 09-07 | ASX Biggest Losers | MT |
| 08-27 | 4DMedical Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 2.01B 1.45B 1.25B 1.18B 1.07B 2B 138B 14B 5.38B 70.23B 5.43B 5.31B 222B | P/E 2026 |
-151x | P/E 2027 * | -54.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.75B 1.26B 1.08B 1.02B 928M 1.74B 120B 12.16B 4.68B 61.02B 4.71B 4.61B 193B | EV / Sales 2026 |
344x | EV / Sales 2027 * | 78x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
Deutsche Boerse AG
| MQ7 | Delayed | |
|
OTC Markets
| FDMDF | Delayed | |
|
Boerse Muenchen
| MQ7 | Real-time | |
|
Tradegate
| MQ7 | Real-time |
Last Transcript : 4DMedical Limited
| 1 day | -3.45% | ||
| 1 week | -6.67% | ||
| Current month | -1.75% | ||
| 1 month | -17.65% | ||
| 3 months | -7.44% | ||
| 6 months | -23.29% | ||
| Current year | -14.50% |
| 1 week | 3.31 |  | 3.61 |
| 1 month | 3.31 | | 4.14 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 2012-11-30 |
Julian Sutton
DFI | Director of Finance/CFO | - | 2026-01-01 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 2012-11-30 |
Lilian Bianchi
CHM | Chairman | - | 2023-11-01 |
John Livingston
BRD | Director/Board Member | - | 2017-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/18/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 3/4/26 | Exercice | Director | 213,464 | 0.0373% | ||
| 3/4/26 | Exercice | Director | 213,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.45% | -6.67% | +77.78% | +469.49% | 1.45B | |
| +1.10% | -0.65% | +24.10% | +18.43% | 225B | |
| -0.19% | -3.62% | +2.55% | -20.00% | 141B | |
| +2.41% | +0.67% | -19.02% | +22.09% | 130B | |
| -0.28% | -10.08% | -58.81% | -21.22% | 62.29B | |
| -2.77% | -6.15% | +8.15% | +12.69% | 48.63B | |
| -0.49% | -1.97% | -20.35% | -15.53% | 49.39B | |
| +2.66% | -2.61% | +15.94% | +29.91% | 41.42B | |
| +1.67% | -0.25% | +35.01% | +55.09% | 40.12B | |
| -0.60% | -4.41% | -20.52% | +44.06% | 31.23B | |
| Average | +0.01% | -3.75% | +4.48% | +59.50% | 77.11B | |
| Weighted average by Cap. | +0.51% | -2.51% | +0.75% | +10.70% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.34M 5.98M 5.15M 4.88M 4.42M 8.3M 571M 57.96M 22.29M 291M 22.46M 21.97M 919M | 22.8M 16.35M 14.09M 13.34M 12.09M 22.69M 1.56B 158M 60.93M 795M 61.41M 60.07M 2.51B |
| Net income | -177M -127M -109M -104M -93.9M -176M -12.13B -1.23B -473M -6.17B -477M -466M -19.5B | -38.5M -27.61M -23.79M -22.53M -20.42M -38.31M -2.64B -268M -103M -1.34B -104M -101M -4.24B |
| Net Debt | -264M -190M -163M -155M -140M -263M -18.12B -1.84B -707M -9.22B -712M -697M -29.13B | -236M -169M -146M -138M -125M -235M -16.18B -1.64B -631M -8.23B -636M -622M -26.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | A$3.360 | -3.45% | 2,768,381 |
| 26-09-10 | A$3.480 | +0.58% | 1,543,114 |
| 26-09-09 | A$3.460 | +3.28% | 3,324,358 |
| 26-09-08 | A$3.350 | -4.83% | 5,082,309 |
| 26-09-07 | A$3.520 | -2.22% | 1,972,748 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
